Frazier Healthcare Partners Promotes Philip Zaorski to General Partner, Plans New York City Office Opening in Summer 2025
ByAinvest
Tuesday, Mar 4, 2025 8:03 am ET1min read
APPN--
Zaorski, who joined Frazier in 2012, has held various deal and portfolio management roles with the firm's investments in AppianRx, Comprehensive Pharmacy Services, Northfield Medical, and Vein Clinics of America [1]. Prior to Frazier, he worked as an Analyst with RBC Capital Markets and holds a B.S. from the Wharton School of Business at the University of Pennsylvania [1].
The new General Partner's contributions to the firm have been significant. Zaorski's ability to lead, execute, and deliver outstanding performance has been recognized by his colleagues [1].
Frazier Healthcare Partners has also been expanding its footprint. The firm has raised over $11 billion for private funds and invested in over 200 companies in 33 years [1]. With the addition of the New York City office, the firm aims to house investment professionals and portfolio operations team members [1].
The new office will be headed by Zaorski, who will relocate to New York to lead the team [1]. This expansion underscores Frazier Healthcare Partners' commitment to identifying and investing in promising healthcare opportunities across the United States.
References:
[1] Business Wire. (2019, October 29). Frazier Healthcare Partners Promotes Ben Magnano, Phil Zaorski and Adds Christina Miller Reszka as Principals. https://www.businesswire.com/news/home/20191029005303/en/
NFBK--
Frazier Healthcare Partners promotes Philip Zaorski to General Partner. The firm is also opening a New York City office in summer 2025, which will be headed by Zaorski. The office will house investment professionals and portfolio operations team members. Frazier has raised over $11 billion for private funds and invested in over 200 companies in 33 years.
Frazier Healthcare Partners, a prominent healthcare investment firm based in Seattle, recently announced several key personnel changes and expansion plans [1]. The firm promoted Philip Zaorski to General Partner and revealed plans to open a new office in New York City in summer 2025.Zaorski, who joined Frazier in 2012, has held various deal and portfolio management roles with the firm's investments in AppianRx, Comprehensive Pharmacy Services, Northfield Medical, and Vein Clinics of America [1]. Prior to Frazier, he worked as an Analyst with RBC Capital Markets and holds a B.S. from the Wharton School of Business at the University of Pennsylvania [1].
The new General Partner's contributions to the firm have been significant. Zaorski's ability to lead, execute, and deliver outstanding performance has been recognized by his colleagues [1].
Frazier Healthcare Partners has also been expanding its footprint. The firm has raised over $11 billion for private funds and invested in over 200 companies in 33 years [1]. With the addition of the New York City office, the firm aims to house investment professionals and portfolio operations team members [1].
The new office will be headed by Zaorski, who will relocate to New York to lead the team [1]. This expansion underscores Frazier Healthcare Partners' commitment to identifying and investing in promising healthcare opportunities across the United States.
References:
[1] Business Wire. (2019, October 29). Frazier Healthcare Partners Promotes Ben Magnano, Phil Zaorski and Adds Christina Miller Reszka as Principals. https://www.businesswire.com/news/home/20191029005303/en/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet